Immediate recovery of acquired von willebrand syndrome after left ventricular assist device explantation: Implications for heart transplantation

ASAIO Journal

Volumn 61, Issue 1, 2015, Pages e1-e4

  Davis, Mary E ^a   Haglund, Nicholas A ^a   Tricarico, Nicole M ^a   Matafonov, Anton ^a   Gailani, David ^a   Maltais, Simon ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

acquired von Willebrand syndrome; cardiac transplantation; left ventricular assist device; perioperative bleeding

Indexed keywords

FIBER OPTIC SENSORS; HEART; PATIENT REHABILITATION; RECOVERY;

ACQUIRED VON WILLEBRAND SYNDROME; CARDIAC TRANSPLANTATION; CLINICAL MANIFESTATION; DENSITOMETRIC ANALYSIS; HEART TRANSPLANTATION; PERIOPERATIVE BLEEDING; VENTRICULAR ASSIST DEVICE; VON WILLEBRAND FACTOR;

LEFT VENTRICULAR ASSIST DEVICES;

BLOOD CLOTTING FACTOR 8; FIBRINOGEN; VITAMIN K GROUP; VON WILLEBRAND FACTOR; MYXOVIRUS RESISTANCE PROTEIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOGENIC SHOCK; CASE REPORT; DENSITOMETRY; DEVICE REMOVAL; HEART TRANSPLANTATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEFT VENTRICULAR ASSIST DEVICE; MALE; MIDDLE AGED; ORTHOTOPIC TRANSPLANTATION; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBOCYTE POOR PLASMA; VON WILLEBRAND DISEASE; ADVERSE EFFECTS; BLOOD; CHEMISTRY; HEART ASSIST DEVICE; METABOLISM; MOLECULAR WEIGHT; POSTOPERATIVE HEMORRHAGE; SHOCK, CARDIOGENIC; VON WILLEBRAND DISEASES;

HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; MYXOVIRUS RESISTANCE PROTEINS; POSTOPERATIVE HEMORRHAGE; SHOCK, CARDIOGENIC; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 84930179535     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0000000000000157     Document Type: Article

References (7)

1. Aaronson KD, Slaughter MS, Miller LW, et al. HeartWare Ventricular Assist Device (HVAD) Bridge to Transplant ADVANCE Trial Investigators: Use of an intrapericardial, continuous- flow, centrifugal pump in patients awaiting heart transplantation. Circulation 125: 3191-3200, 2012
2. Feldman D, Pamboukian SV, Teuteberg JJ, et al. International Society for Heart and Lung Transplantation: The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: Executive summary. J Heart Lung Transplant 32: 157-187, 2013
3. Dassanayaka S, Slaughter MS, Bartoli CR. Mechanistic pathway(s) of acquired von willebrand syndrome with a continuous-flow ventricular assist device: In vitro findings. ASAIO J 59: 123-129, 2013
4. U riel N, Pak SW, Jorde UP, et al. Acquired von Willebrand syndrome after continuous-flow mechanical device support contributes to a high prevalence of bleeding during long-term support and at the time of transplantation. J Am Coll Cardiol 56: 1207-1213, 2010
5. Davis ME, Haglund NA, Tricarico NM, Keebler ME, Maltais S. Development of acquired von Willebrand syndrome during short-term micro axial pump support: Implications for bleeding in a patient bridged to a long-term continuous flow left ventricular assist device. ASAIO J 60(3): 355-7 2014
6. Klovaite J, Gustafsson F, Mortensen SA, Sander K, Nielsen LB. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). J Am Coll Cardiol 53: 2162-2167, 2009
7. Pruthi RK, Daniels TM, Heit JA, Chen D, Owen WG, Nichols WL. Plasma von Willebrand factor multimer quantitative analysis by in-gel immunostaining and infrared fluorescent imaging. Thromb Res 126: 543-549, 2010